Opportunity Information: Apply for PA 06 445
Apply for PA 06 445
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "The Development of Frontal Cortex and Limbic System and their roles in Drug Abuse or Mental Health (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Jun 5, 2006.
- Applicants must submit their applications by Sep 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Independent school districts County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) State governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Applicants may submit more than one application, provided each application is scientifically distinct.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity "The Development of Frontal Cortex and Limbic System and their roles in Drug Abuse or Mental Health (R21)" (Funding Opportunity Number PA-06-445) supports early-stage, exploratory neuroscience projects focused on how key brain systems develop and how that development relates to substance use and mental health conditions. The scientific emphasis is on the frontal and prefrontal cortices alongside subcortical limbic regions, including midbrain and basal forebrain structures that are central to emotion, motivation, reward processing, and higher-order cognitive control. The overall intent is to fund basic research that clarifies the core cellular and molecular mechanisms guiding how these circuits form, mature, and function, especially because these same circuits are heavily implicated in addiction vulnerability and psychiatric symptoms.
A central priority of the FOA is understanding how exposure to drugs of abuse can alter normal brain development. Applicants are encouraged to investigate how drugs may disrupt developmental processes at the cellular and molecular level in the circuits that later influence drug seeking, reinforcement, craving, and compulsive use. This includes work aimed at explaining how developmental changes in frontal cortical control systems and limbic reward and stress systems might shape addiction risk across the lifespan, particularly during sensitive windows when these networks are still maturing. The FOA also highlights interest in how atypical developmental trajectories, even without drug exposure, might contribute to psychiatric disorders thought to have developmental origins, meaning projects can address developmental mechanisms that later manifest as cognitive, emotional, or motivational dysfunction linked to mental illness.
This announcement uses the NIH R21 exploratory/developmental grant mechanism, which is generally intended for innovative, higher-risk ideas, pilot studies, and proof-of-concept projects that can open up new research directions. The FOA runs in parallel with a companion opportunity of the same scientific scope that uses the R01 mechanism (PA-06-444), which typically supports larger and more mature research programs. Because proposed studies can vary widely in approach and scope, the NIH notes that award size and duration may vary across funded projects, but the listed award ceiling is $200,000. The number of awards and total funding depend on the number of applications received, their scientific quality, and their proposed budgets and timelines.
From an administrative standpoint, this is a discretionary grant opportunity in the broad area of education and health research, tied to CFDA numbers 93.242 (Mental Health Research Grants) and 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement. The opportunity was posted June 5, 2006, and it used multiple receipt dates, with the final listed closing date of September 7, 2009, and an archive date of October 7, 2009 (meaning it is no longer active, but still useful as a reference for NIH priorities and past funding interests).
Eligibility is broad. Applicants may include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses), and a wide range of government entities (state, county, city/township, special district), as well as Native American tribal governments and tribal organizations. The FOA explicitly states that foreign institutions are eligible to apply, eligible federal agencies may apply, and faith-based or community-based organizations may apply. On the investigator side, NIH encourages any qualified individual with the necessary expertise and resources to serve as PD/PI, and it specifically encourages applications from individuals from underrepresented racial and ethnic groups and individuals with disabilities. Multiple applications are allowed as long as each one is scientifically distinct.
In practical terms, a strong fit for this FOA would be a project that probes how frontal-prefrontal and limbic circuitry is built and tuned over development, and then links those developmental mechanisms to outcomes relevant to addiction or psychiatric disorders. That can include studying how reward-related drug effects, responses to psychotherapeutic agents, or the emergence of cognitive and emotional regulation depend on the maturation of these neural systems. The key theme across the announcement is developmental neuroscience as the foundation for understanding later vulnerability, resilience, and pathophysiology in both drug abuse and mental health.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this NIH grant?
The opportunity is titled "The Development of Frontal Cortex and Limbic System and their roles in Drug Abuse or Mental Health (R21)" and the Funding Opportunity Number is PA-06-445.
What is the main purpose of this funding opportunity?
This FOA supports early-stage, exploratory neuroscience research focused on how key brain systems develop and how that development relates to substance use and mental health conditions. The intent is to fund basic research that clarifies core cellular and molecular mechanisms guiding how relevant neural circuits form, mature, and function, especially because these circuits are strongly implicated in addiction vulnerability and psychiatric symptoms.
Which brain systems and regions are emphasized?
The scientific emphasis is on the frontal and prefrontal cortices and subcortical limbic regions, including midbrain and basal forebrain structures. These systems are described as central to emotion, motivation, reward processing, and higher-order cognitive control.
What types of research questions are a strong fit for this FOA?
A strong fit would be a project that probes how frontal-prefrontal and limbic circuitry is built and tuned over development, then links those developmental mechanisms to outcomes relevant to addiction or psychiatric disorders. Projects may focus on how these systems form, mature, and function, and how developmental changes relate to later vulnerability or resilience.
Does this FOA focus on drug exposure effects on brain development?
Yes. A central priority is understanding how exposure to drugs of abuse can alter normal brain development. Applicants are encouraged to investigate how drugs may disrupt developmental processes at the cellular and molecular level in circuits that influence drug seeking, reinforcement, craving, and compulsive use.
Is research on atypical development without drug exposure also relevant?
Yes. The FOA also highlights interest in atypical developmental trajectories that may contribute to psychiatric disorders with developmental origins. Projects can address developmental mechanisms that later manifest as cognitive, emotional, or motivational dysfunction linked to mental illness, even without drug exposure.
What is the grant mechanism used by this opportunity?
This announcement uses the NIH R21 exploratory/developmental grant mechanism, which is generally intended for innovative, higher-risk ideas, pilot studies, and proof-of-concept projects that can open up new research directions.
Is there a related NIH opportunity with a different mechanism?
Yes. The FOA runs in parallel with a companion opportunity of the same scientific scope that uses the R01 mechanism (PA-06-444), which typically supports larger and more mature research programs.
What is the maximum award amount mentioned?
The listed award ceiling is $200,000. The NIH also notes that award size and duration may vary across funded projects.
How are the number of awards and total funding determined?
The number of awards and total funding depend on the number of applications received, their scientific quality, and the proposed budgets and timelines.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
What are the CFDA numbers associated with this opportunity?
This discretionary grant opportunity is tied to CFDA 93.242 (Mental Health Research Grants) and 93.279 (Drug Abuse and Addiction Research Programs).
When was this opportunity posted, and is it still active?
The opportunity was posted on June 5, 2006. It used multiple receipt dates, with a final listed closing date of September 7, 2009, and an archive date of October 7, 2009. This means it is no longer active, though it may still be useful as a reference for NIH priorities and past funding interests.
Who is eligible to apply as an organization?
Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses), and many government entities (state, county, city/township, special district). It also includes Native American tribal governments and tribal organizations.
Are foreign institutions eligible to apply?
Yes. The FOA explicitly states that foreign institutions are eligible to apply.
Can federal agencies apply?
Yes. The FOA states that eligible federal agencies may apply.
Can faith-based or community-based organizations apply?
Yes. The FOA explicitly states that faith-based or community-based organizations may apply.
Who is eligible to serve as the PD/PI?
NIH encourages any qualified individual with the necessary expertise and resources to serve as PD/PI. The FOA specifically encourages applications from individuals from underrepresented racial and ethnic groups and individuals with disabilities.
Are multiple applications allowed?
Yes. Multiple applications are allowed as long as each one is scientifically distinct.
What kinds of outcomes or topics can projects connect to, according to the FOA?
Projects can connect developmental mechanisms in frontal-prefrontal and limbic systems to outcomes relevant to addiction and mental health, including drug seeking, reinforcement, craving, compulsive use, and broader cognitive, emotional, and motivational dysfunction implicated in psychiatric symptoms.
Does the FOA mention sensitive developmental windows or lifespan considerations?
Yes. The FOA highlights interest in addiction risk across the lifespan, particularly during sensitive windows when frontal cortical control networks and limbic reward and stress systems are still maturing.
Does the FOA allow studying responses to therapeutic or psychoactive agents in the context of development?
Yes. The FOA notes that strong-fit projects can include studying how reward-related drug effects, responses to psychotherapeutic agents, or the emergence of cognitive and emotional regulation depend on the maturation of these neural systems.
What is the overall theme tying the scientific topics together?
The unifying theme is developmental neuroscience as a foundation for understanding later vulnerability, resilience, and pathophysiology in both drug abuse and mental health.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Behavioral and Social Research on Disasters and Health (R21)
Previous opportunity: Human Biospecimen Resources for Aging Research (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 06 445
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 06 445) also looked into and applied for these:
| Funding Opportunity |
|---|
| Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and Women and Sex/Gender Differences (R36) Apply for PAR 06 476 Funding Number: PAR 06 476 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Behavioral and Integrative Treatment Development Program (R21) Apply for PA 06 487 Funding Number: PA 06 487 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Behavioral and Integrative Treatment Development Program (R03) Apply for PA 06 488 Funding Number: PA 06 488 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R21) Apply for PA 06 496 Funding Number: PA 06 496 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R03) Apply for PA 06 497 Funding Number: PA 06 497 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis(R21) Apply for PA 06 499 Funding Number: PA 06 499 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R03) Apply for PA 06 502 Funding Number: PA 06 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R21) Apply for PA 06 501 Funding Number: PA 06 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cancer Institute (NCI) Cancer Education and Career Development Program (R25) Apply for PAR 06 511 Funding Number: PAR 06 511 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 06 461 Funding Number: PA 06 461 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R33) Apply for PA 06 462 Funding Number: PA 06 462 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award R21/R33) Apply for PA 06 463 Funding Number: PA 06 463 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R03) Apply for PAR 06 520 Funding Number: PAR 06 520 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Dissemination and Implementation Research in Health (R21) Apply for PAR 06 521 Funding Number: PAR 06 521 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Translational Research for the Prevention and Control of Diabetes and Obesity (R18) Apply for PAR 06 532 Funding Number: PAR 06 532 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral Science Track Award for Rapid Transition (B/START) (R03) Apply for PAR 06 541 Funding Number: PAR 06 541 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Apply for PA 07 022 Funding Number: PA 07 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Focal Cognitive Deficits in CNS Disorders (R03) Apply for PA 07 034 Funding Number: PA 07 034 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Focal Cognitive Deficits in CNS Disorders (R21) Apply for PA 07 035 Funding Number: PA 07 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 07 049 Funding Number: PAR 07 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 06 445", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.